Uncategorized
Share this news article...
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Email this to someone
email

MedReleaf to collaborate with CFL Alumni Association in studying benefits of medical cannabis in managing chronic pain

 

 

 

 

 

MedReleaf Corp. (TSX:LEAF) today announced it will collaborate with the Canadian Football League Alumni Association in conducting an observational study on the benefits of medical cannabis in treating chronic pain and related ailments in retired professional athletes. 

 

 

MedReleaf and the CFLAA recognize the opportunity to collaborate on this important study which will bring greater awareness to the potential health benefits of using medical cannabis in the treatment of ailments that include chronic pain. The joint observational study is scheduled to begin in the summer of 2018 with volunteer CFLAA member participants.   

 

 

“We are excited to collaborate with the CFL Alumni Association on this significant observational study with legends in the Canadian athletic arena,” said Neil Closner, MedReleaf CEO. “Through ongoing research, our understanding of the benefits of medical cannabis has grown significantly and we welcome the opportunity to apply our expertise in validating new patient therapies and contributing to positive patient outcomes for this exceptional group of former athletes.” 

 

 

“The CFLAA has always sought to make a difference by providing support to our alumni, many of whom experienced medical challenges following their athletic careers,” said Leo Ezerins, CFLAA Executive Director.  “In collaborating with MedReleaf we hope to gain further insight into the benefits of medical cannabis in managing chronic pain – insight that could be invaluable to our almost 2,000 alumni members.”

 

 

About MedReleaf Corp.

 

 

Canada’s most awarded licensed producer, MedReleaf is an R&D-driven company dedicated to innovation, operational excellence and the production of top-quality cannabis.  Sourced from around the world and carefully cultivated in one of two state-of-the-art ICH-GMP and ISO 9001 certified facilities in Ontario Canada, with a third facility currently in development, premium MedReleaf products are delivered to the global medical market. MedReleaf serves the therapeutic needs of patients seeking safe, consistent and effective medical cannabis and provides a compelling product offering for the adult-use recreational consumer. 

 

 

About the CFLAA

 

 

The Canadian Football League Alumni Association is 2,000 members strong and unites former CFL players, from across Canada, in support of sport, youth, and health related charitable causes.  The CFLAA fosters a lifelong relationship between the Canadian Football League and its former players with a special focus on providing support to those alumni experiencing medical challenges resulting from their former athletic careers.  

 

Posted May 24, 2018

Share this news article...
Share on LinkedIn
Linkedin
Share on Facebook
Facebook
Tweet about this on Twitter
Twitter
Email this to someone
email

MORE or "UNCATEGORIZED"


Khiron Announces Closing of $28.75 Million Bought Deal Financing Including Full Exercise of Over-Allotment Option

Khiron Life Sciences Corp. (TSX-V:KHRN) (OTCQB:KHRNF), a cannabis... READ MORE

May 28, 2019

Harborside Closes C$19.65 Million Financing

FLRish Inc. d/b/a/ Harborside, a California corporation which man... READ MORE

May 28, 2019

TerrAscend Announces Closing on $69 Million Non-Brokered Private Placement

TerrAscend Corp. (CSE:TER) (OTCQX:TRSSF) has completed its previo... READ MORE

May 28, 2019

Construction of a hydroelectric generating station for the energy transition in the Inukjuak off-grid system

Innergex Renewable Energy Inc. (TSX: INE) the Pituvik Landholding... READ MORE

May 27, 2019

C21 Investments completes acquisition of Swell Companies

C21 Investments Inc. (CSE: CXXI) (OTC: CXXIF) today announced tha... READ MORE

May 27, 2019

Copyright 2026 The Venture Report